These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38371040)

  • 61. Diagnostic Sensitivity of Saliva and Other Respiratory Tract Samples of SARS-CoV-2 Variants in Patients with COVID-19.
    Lawrence Panchali MJ; Kim CM; Lee YM; Seo JW; Kim DY; Yun NR; Kim DM
    Microbiol Spectr; 2023 Mar; 11(2):e0307622. PubMed ID: 36976007
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19.
    Sakamaki I; Morinaga Y; Tani H; Takegoshi Y; Fukui Y; Kawasuji H; Ueno A; Miyajima Y; Wakasugi M; Kawagishi T; Kuwano H; Hatano T; Shibuya T; Okudera H; Yamamoto Y
    J Infect Chemother; 2020 Dec; 26(12):1324-1327. PubMed ID: 32900659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.
    Ballotta L; Simonetti O; D'Agaro P; Segat L; Koncan R; Martinez-Orellana P; Dattola F; Orsini E; Marcello A; Dal Monego S; Licastro D; Misin A; Mohamed S; Sbisà E; Lucchini E; De Sabbata GM; Zaja F; Luzzati R
    Front Oncol; 2022; 12():945060. PubMed ID: 36249044
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report.
    Rahimian N; Alibeik N; Pishgar E; Dini P; Abolmaali M; Mirzaasgari Z
    Iran J Med Sci; 2022 Jul; 47(4):385-388. PubMed ID: 35919075
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.
    Dou C; Xie X; Peng Z; Tang H; Jiang Z; Zhong Z; Tang J
    Diabetes Res Clin Pract; 2020 Aug; 166():108300. PubMed ID: 32663490
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis.
    Tao K; Tzou PL; Kosakovsky Pond SL; Ioannidis JPA; Shafer RW
    Microbiol Spectr; 2022 Aug; 10(4):e0092622. PubMed ID: 35700134
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case.
    Tatham L; Kipar A; Sharp J; Kijak E; Herriott J; Neary M; Box H; Toledo EG; Valentijn A; Cox H; Pertinez H; Curley P; Arshad U; Rajoli RK; Rannard S; Stewart J; Owen A
    bioRxiv; 2023 Mar; ():. PubMed ID: 35118468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
    Palomba E; Carrabba M; Zuglian G; Alagna L; Saltini P; Fortina V; Hu C; Bandera A; Fabio G; Gori A; Muscatello A
    Int J Infect Dis; 2021 Sep; 110():338-340. PubMed ID: 34332085
    [TBL] [Abstract][Full Text] [Related]  

  • 71. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
    Lu S; Wei N; Jiang J; Wu L; Sheng J; Zhou J; Fang Q; Chen Y; Zheng S; Chen F; Liang T; Hu S
    J Affect Disord; 2020 Dec; 277():337-340. PubMed ID: 32858315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case Report: A Severe Paediatric Presentation of COVID-19 in APDS2 Immunodeficiency.
    Sanchez Clemente N; Penner J; Breuer J; Ip W; Booth C
    Front Immunol; 2022; 13():881259. PubMed ID: 35707532
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful treatment with steroid pulse therapy for a COVID-19 case with progressive respiratory failure during treatment for pleural metastasis of breast cancer.
    Jimbo H; Horimoto Y; Hiki M; Tabe Y; Watanabe J; Saito M; Naito T
    Surg Case Rep; 2022 May; 8(1):96. PubMed ID: 35576027
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2.
    Hirotsu Y; Kobayashi H; Kakizaki Y; Saito A; Tsutsui T; Kawaguchi M; Shimamura S; Hata K; Hanawa S; Toyama J; Miyashita Y; Omata M
    Med; 2023 Nov; 4(11):813-824.e4. PubMed ID: 37683636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants.
    Giannitsioti E; Mavroudis P; Speggos I; Katsoulidou A; Pantazis N; Loupis T; Daniil I; Rekleiti N; Damianidou S; Louka C; Sidiropoulou C; Kranidiotis G; Velentza L; Stamati A; Kasidiaraki M; Efstratiadi E; Linardaki G; Chrysos G; Zarkotou O; Zoi K; Tryfinopoulou K; Gerakari S
    Infect Dis (Lond); 2023 Oct; 55(10):706-715. PubMed ID: 37427461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series.
    Fernandes G; Devresse A; Scohy A; De Greef J; Yombi JC; Belkhir L; Darius T; Mourad M; Buemi A; Kabamba B; Goffin E; Kanaan N
    Kidney Med; 2022 Jun; 4(6):100470. PubMed ID: 35493029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Teaching Case: Persistent COVID-19 Pneumonia Resembling Cryptogenic Organizing Pneumonia in a Patient With Remitted Lymphoma.
    Yanagihara T; Kadowaki M; Otsuka J; Ishimatsu A; Taguchi K; Moriuchi Y; Ogata H; Moriwaki A; Yoshida M
    Cureus; 2023 Nov; 15(11):e48319. PubMed ID: 38060718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.